Clinical Trials Directory

Trials / Unknown

UnknownNCT06024486

Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin Ratio in Juvenile Idiopathic Arthritis

Correlation of Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin Ratio With Disease Activity in Juvenile Idiopathic Arthritis

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

The fibrinogen to albumin ratio (FAR) and C-reactive protein to albumin ratio (CAR) have emerged as useful biomarkers to predict systemic inflammation. The aim here is to investigate the relation between FAR/CAR and Juvenile arthritis disease activity score (JASDAS27) in Juvenile idiopathic arthritis (JIA)

Detailed description

The JADAS27 includes a selected count of the following joints: cervical spine, elbows, wrists, metacarpophalangeal joints (from first to third), proximal interphalangeal joints, hips, knees and ankles.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTfibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)measurement of serum albumin, fibrinogen and CRP

Timeline

Start date
2023-11-01
Primary completion
2024-05-01
Completion
2024-07-01
First posted
2023-09-06
Last updated
2023-10-06

Source: ClinicalTrials.gov record NCT06024486. Inclusion in this directory is not an endorsement.